The prospect of rising interest rates has some pension sponsors concerned about the limited supply of long-term corporate bonds. Vanguard Lead Investment Actuary Brett Dutton explains why such concerns need not translate to immediate action.
Investments
Benefit from expertise on target-date funds, indexing,
portfolio construction, and risk management.
Recent posts
If you’ve ever run a marathon, you know the hardest part is the dedication it takes to get to the starting line. The same can be said of nonprofits wanting to build a private equity program.
Bond indexers, don’t shed a tear for QE
Categories: InvestmentsThe Fed is unwinding quantitative easing. This should not have negative implications for bond yields or fixed income index investing. The Bloomberg Barclays U.S. Aggregate Bond Index is still an appropriate measure of the fixed income market.
John Hollyer, head of Vanguard’s Fixed Income Group, discusses the role emerging market bonds can play in a portfolio and how the new Vanguard Emerging Markets Fund further rounds out our stable of low-cost, active bond funds.
Guest blogger Jonathan Horton, global director of change management at FTSE Russell, discusses what makes a great index. He describes FTSE’s unique approach, and suggests that organizations look under the hood of index construction to determine what indexes align best with their goals.
Guest blogger David Barclay, chief operating officer for CRSP, discusses what makes a great index. He describes CRSP’s unique approach, and suggests that organizations look under the hood of index construction to determine what indexes align best with their goals.
A tipping point for target-date funds
Categories: InvestmentsIn October 2017, Vanguard plan participants reached a tipping point: Half of all Vanguard participants are invested in a single target-date fund—and 57% are invested solely in a professionally managed allocation.
